Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
1,35 EUR | -3,57 % | +12,00 % | -85,79 % |
17/05 | Actualización del sector: Los valores del sector sanitario, mixtos a última hora de la tarde | MT |
17/05 | Actualización del sector: Atención sanitaria | MT |
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutics for Rare Seizures
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 25 | 100,0 % | 31 | 100,0 % | +21,63 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/09/18 |
Steven Pfanstiel
DFI | Director of Finance/CFO | 51 | 12/04/21 |
Joseph Hulihan
CTO | Chief Tech/Sci/R&D Officer | 68 | 06/11/19 |
Chief Tech/Sci/R&D Officer | - | - | |
Sonya Weigle
IRO | Public Communications Contact | - | 01/09/21 |
Christy Shafer
PRN | Corporate Officer/Principal | 48 | 10/11/20 |
General Counsel | - | - | |
Thomas Lyons
PRN | Corporate Officer/Principal | - | 01/01/18 |
Alex Aimetti
PRN | Corporate Officer/Principal | - | - |
Martha Manning
LAW | General Counsel | 69 | 15/06/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Tim Mayleben
BRD | Director/Board Member | 63 | 01/12/08 |
Scott Braunstein
CEO | Chief Executive Officer | 60 | 05/09/18 |
Elan Ezickson
BRD | Director/Board Member | 60 | 12/12/19 |
Seth Fischer
BRD | Director/Board Member | 68 | 06/09/16 |
Sara Nochur
BRD | Director/Board Member | 63 | 22/03/21 |
Sarah Noonberg
BRD | Director/Board Member | 56 | 16/05/23 |
Director/Board Member | 41 | 26/01/23 | |
Charles Austin
BRD | Director/Board Member | 68 | 29/07/20 |
Marvin Johnson
BRD | Director/Board Member | 61 | 18/04/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 54 941 081 | 54 403 089 ( 99,02 %) | 7 307 ( 0,0133 %) | 99,02 % |
Información de la empresa
Marinus Pharmaceuticals, Inc.
5 Radnor Corporate Center 100 Matsonford Road
19087-5279, Radnor
+484 801 4670
http://www.marinuspharma.comRevisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+42,83 % | 748 mil M | |
+34,11 % | 598 mil M | |
-5,70 % | 356 mil M | |
+18,06 % | 325 mil M | |
+4,63 % | 283 mil M | |
+17,02 % | 245 mil M | |
+9,26 % | 211 mil M | |
-4,21 % | 209 mil M | |
+2,43 % | 166 mil M |
- Bolsa de valores
- Acciones
- Acción MRNS
- Acción 61Y
- Empresa Marinus Pharmaceuticals, Inc.